Author

Arjan Bredenoord 1

1 Department Of Gastro

A novel budesonide orodispersible tablet formulation is highly effective to maintain endoscopic inflammatory remission and even complete endoscopic remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Luc Biedermann, Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen E. Attwood, Alex Straumann

A novel oral budesonide formulation is highly effective for induction of remission in patients with active eosinophilic esophagitis: Results from the 6-weeks open-label treatment phase of EOS-2 trial

Alfredo J. Lucendo, Christoph Schlag, Stephan Miehlke, Luc Biedermann, Cecilio Santander Vaquero, Dirk Hartmann, Jamal Hayat, Petr Hruz, Constanza Ciriza De Los Ríos, Arjan Bredenoord, Michael Vieth, Ralph Müller, Roland Greinwald, Alex Straumann

Belching and aerophagia

Arjan Bredenoord

Budesonide orodispersible tablets are superior to maintain and even further improve quality of life in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Christoph Schlag, Luc Biedermann, Alfredo J. Lucendo, Stephan Miehlke, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen E. Attwood, Alex Straumann

Budesonide orodispersible tablets are superior to maintain combined clinical and histological remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Luc Biedermann, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Stefan Schubert, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen

CLINICAL AND ENDOSCOPIC CHARACTERISTICS CAN HELP DISTINGUISH PSEUDOACHALASIA FROM ACHALASIA

Fraukje Anna-marie Ponds, Ingmar Van Raath, André Smout, Arjan Bredenoord

Clinical presentation and epidemiology

Arjan Bredenoord

DUPILUMAB EFFICACY AND SAFETY IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PART A OF A RANDOMIZED, PLACEBO-CONTROLLED THREE-PART, PHASE 3 STUDY

Evan S Dellon, Marc E. Rothenberg, Margaret H. Collins, Ikuo Hirano, Mirna Chehade, Arjan Bredenoord, Alfredo J. Lucendo, Jonathan Spergel, Qiong Zhao, Jennifer D. Hamilton, Bethany Beazley, Isabelle Guillemin, Siddhesh Kamat, Leda Mannent, Marcella Ruddy, Elizabeth Laws, Bolanle Akinlade, Nikhil Amin, Allen Radin, Brad

EFFICACY AND SAFETY OF BUDESONIDE ORODISPERSIBLE TABLETS IN ACTIVE EOSINOPHILIC OESOPHAGITIS: RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PIVOTAL, EUROPEAN MULTICENRE TRIAL (EOS-1)

Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Ulrike von Arnim, Javier Molina Infante, Dirk Hartmann, Arjan Bredenoord, Constanza Ciriza De Los Ríos, Stefan Schubert, Stefan Brueckner, Ahmed Madisch, Jamal Hayat, Jan Tack, Alain Schoepfer, Roland Greinwald, Ralph Mueller, Stephen E.

EFFICACY OF PNEUMODILATION IN ACHALASIA AFTER FAILED HELLER MYOTOMY

Caroline Saleh, Fraukje Anna-marie Ponds, Marlies P Schijven, André Smout, Arjan Bredenoord

Item 1 - 10 / 80
1
2 3 4 5 6 7 8